About us

Technology based innovative life-science company committed to pursuing
for healthier and cleaner world


BioActs’ progress to create innovations
for healthier world


  • 2019

    Attracted the third round external capital funding.

  • 2018

    Established MOU with Korea Atomic Energy Research Institute (KAERI), Yonsei University
    (Department of Pharmacy), and Chonnam National University (College of Veterinary Medicin).

  • 2017

    Established MOU with Asan Medical center and Konkuk University Bioimaging Center.
    Attracted the second round external capital funding.

  • 2016

    Attracted the first round external capital funding.

  • 2015

    Change company name to BioActs, secure external fund.
    Established distributorship agreement and MOU with Seoulin Bioscience Inc.

  • 2014

    Selected as a member of K-club of Korea Institute of Science and Technology.

  • 2013

    Recognized as a Visionary Company by Incheon Metropolitan city.
    Established MOU between BioActs and National Institute of Imaging and
    Bioengineering, an affiliated institute of NIH.

  • 2012

    Biological division business marketing and sales launched.
    Established MOU with Chonnam National University Hwasun Hospital.

  • 2010

    Certified as an Advanced Technology Center (ATC) for biomolecular labeling materials.
    The New Excellent Technology (NET) certification acquired


  • 2009

    Biological business division (BioActs) established.

  • 2005

    Antibacterial dyes and blue fluorescent OLED material production begin.

  • 2002

    Ningbo Factory and Hangzhou Sales Corporation in China launched.

  • 2001

    Awarded the presidential commendation and 5 million dollars export tower.


  • 1991

    Affiliated R&D center established; opened an era of innovative growth.

  • 1976

    Corporation established; opened an era of creation and exploration.